Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Mary Jo Larson$suffix/text()$suffix/text(), Cheryl Browne$suffix/text()$suffix/text(), Ruslan V. Nikitin$suffix/text()$suffix/text(), Nikki R. Wooten$suffix/text()$suffix/text(), Sarah Ball$suffix/text()$suffix/text(), Rachel Sayko Adams$suffix/text()$suffix/text() & Kelly Barth$suffix/text()$suffix/text(). (2018) Physicians report adopting safer opioid prescribing behaviors after academic detailing intervention. Substance Abuse 39:2, pages 218-224.
Read now
Read now
Arthur G. Lipman. (2014) Perspective and Balance on Opioid Misuse. Journal of Pain & Palliative Care Pharmacotherapy 28:1, pages 2-3.
Read now
Read now
Marc L. Fleming, Hitesh Chandwani, Jamie C. Barner, Stephanie N. Weber & Tony T. Okoro. (2013) Prescribers and Pharmacists Requests for Prescription Monitoring Program (PMP) Data: Does PMP Structure Matter?. Journal of Pain & Palliative Care Pharmacotherapy 27:2, pages 136-142.
Read now
Read now
Julie Worley. (2012) Prescription Drug Monitoring Programs, a Response to Doctor Shopping: Purpose, Effectiveness, and Directions for Future Research. Issues in Mental Health Nursing 33:5, pages 319-328.
Read now
Read now
Lance Feldman, Kristi Skeel Williams, John Coates & Michele Knox. (2011) Awareness and Utilization of a Prescription Monitoring Program Among Physicians. Journal of Pain & Palliative Care Pharmacotherapy 25:4, pages 313-317.
Read now
Read now
Articles from other publishers (22)
Louisa Picco, Tina Lam, Sarah Haines & Suzanne Nielsen. (2021) How prescription drug monitoring programs influence clinical decision-making: A mixed methods systematic review and meta-analysis. Drug and Alcohol Dependence 228, pages 109090.
Crossref
Crossref
Austin Arnold, John P. Bentley, Amit Patel & Erin Holmes. (2021) Predictors of pharmacists’ likelihood to query prescription drug monitoring program databases. Journal of the American Pharmacists Association 61:5, pages 614-622.e3.
Crossref
Crossref
Alysia Robinson, Maria N Wilson, Jill A Hayden, Emily Rhodes, Samuel Campbell, Peter MacDougall & Mark Asbridge. (2021) Health Care Provider Utilization of Prescription Monitoring Programs: A Systematic Review and Meta-Analysis. Pain Medicine 22:7, pages 1570-1582.
Crossref
Crossref
Julia Dickson-Gomez, Erika Christenson, Margaret Weeks, Carol Galletly, Jennifer Wogen, Antoinette Spector, Madelyn McDonald & Jessica Ohlrich. (2021) Effects of Implementation and Enforcement Differences in Prescription Drug Monitoring Programs in 3 States: Connecticut, Kentucky, and Wisconsin. Substance Abuse: Research and Treatment 15, pages 117822182199234.
Crossref
Crossref
Andrew W. Hunt, Kathleen Clegg, Christina M. Delos Reyes, Maureen Riley-Behringer, Stephen Zyzanski & James J. Werner. (2019) Characteristics and Red Flag Correlates of Psychiatric Outpatients in a Mandated-Use Prescription Drug Monitoring Program State: A PBRN Card Study. Addictive Disorders & Their Treatment 18:1, pages 36-43.
Crossref
Crossref
Benjamin C. Sun, Christina J. Charlesworth, Nicoleta Lupulescu-Mann, Jenny I. Young, Hyunjee Kim, Daniel M. Hartung, Richard A. Deyo & K. John McConnell. (2018) Effect of Automated Prescription Drug Monitoring Program Queries on Emergency Department Opioid Prescribing. Annals of Emergency Medicine 71:3, pages 337-347.e6.
Crossref
Crossref
Neal A. Carnes, Eric R. Wright & Connor W. Norwood. (2017) A qualitative analysis of prescribers' and dispensers' views on improving prescription drug monitoring programs. Research in Social and Administrative Pharmacy 13:6, pages 1167-1174.
Crossref
Crossref
John T. Finnell, Robert K. Twillman, Stephanie A. Breslan, Jan Schultz & Lyerka Miller. (2017) The Role of Continuing Medical Education in Increasing Enrollment in Prescription Drug Monitoring Programs. Clinical Therapeutics 39:9, pages 1896-1902.e2.
Crossref
Crossref
Kelly S. Barth, Sarah Ball, Rachel S. Adams, Ruslan Nikitin, Nikki R. Wooten, Zaina P. Qureshi & Mary J. Larson. (2017) Development and Feasibility of an Academic Detailing Intervention to Improve Prescription Drug Monitoring Program Use Among Physicians. Journal of Continuing Education in the Health Professions 37:2, pages 98-105.
Crossref
Crossref
Eric R. Wright, Neal A. Carnes, Wyndy Greene Smelser & Ben Lennox Kail. (2017) Professional Status and Physicians’ Views of Expanding Governmental Oversight of Prescribing Drugs. Socius: Sociological Research for a Dynamic World 3, pages 237802311770764.
Crossref
Crossref
Y. Bao, Y. Pan, A. Taylor, S. Radakrishnan, F. Luo, H. A. Pincus & B. R. Schackman. (2016) Prescription Drug Monitoring Programs Are Associated With Sustained Reductions In Opioid Prescribing By Physicians. Health Affairs 35:6, pages 1045-1051.
Crossref
Crossref
Robert J. Smith, Austin S. Kilaru, Jeanmarie Perrone, Breah Paciotti, Frances K. Barg, Sarah M. Gadsden & Zachary F. Meisel. (2015) How, Why, and for Whom Do Emergency Medicine Providers Use Prescription Drug Monitoring Programs?. Pain Medicine 16:6, pages 1122-1131.
Crossref
Crossref
Jennifer A. Gershman, Jason A. Gershman, Andrea D. Fass & Ioana Popovici. (2014) Evaluation of Florida Physicians' Knowledge and Attitudes Toward Accessing the State Prescription Drug Monitoring Program as a Prescribing Tool. Pain Medicine 15:12, pages 2013-2019.
Crossref
Crossref
Paul Gavaza, Marc Fleming & Jamie C. Barner. (2014) Examination of psychosocial predictors of Virginia pharmacists' intention to utilize a prescription drug monitoring program using the theory of planned behavior. Research in Social and Administrative Pharmacy 10:2, pages 448-458.
Crossref
Crossref
Marc L. Fleming, Jamie C. Barner, Carolyn M. Brown, Marvin D. Shepherd, Scott Strassels & Suzanne Novak. (2014) Using the theory of planned behavior to examine pharmacists' intention to utilize a prescription drug monitoring program database. Research in Social and Administrative Pharmacy 10:2, pages 285-296.
Crossref
Crossref
Julie Worley. (2014) What Prescribers Can Learn From Doctor Shoppers. The Journal for Nurse Practitioners 10:2, pages 75-82.
Crossref
Crossref
Cathy L. Campbell, Diane E. Boyer, Lisa C. Campbell & Virginia Rovynak. (2012) Pain Management Topics of Interest for Nurses in Rural Appalachia. The Journal of Continuing Education in Nursing 43:6, pages 267-276.
Crossref
Crossref
Gretchen L. Peirce, Michael J. Smith, Marie A. Abate & Joel Halverson. (2012) Doctor and Pharmacy Shopping for Controlled Substances. Medical Care 50:6, pages 494-500.
Crossref
Crossref
Steven D. LeMire, Sarah G. Martner & Cheryl Rising. (2012) Advanced Practice Nurses' Use of Prescription Drug Monitoring Program Information. The Journal for Nurse Practitioners 8:5, pages 383-405.
Crossref
Crossref
Julie Worley & Joanne M. Hall. (2012) Doctor Shopping: A Concept Analysis. Research and Theory for Nursing Practice 26:4, pages 262-278.
Crossref
Crossref
Benedikt Fischer, Wayne Jones, Murray Krahn & Jürgen Rehm. (2011) Differences and over‐time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005–2010. Pharmacoepidemiology and Drug Safety 20:12, pages 1269-1277.
Crossref
Crossref
Timothy R. Ulbrich, Colleen A. Clark Dula, Christopher G. Green, Kyle Porter & Marialice S. Bennett. (2010) Factors influencing community pharmacists' enrollment in a state prescription monitoring program. Journal of the American Pharmacists Association 50:5, pages 588-594.
Crossref
Crossref